[1]中国肾性贫血诊疗临床实践指南. 中华医学杂志 2021; 101(20): 1463-1502.
[2]Masumoto M, Kuragano T, Takata C, Fukui R, Mihara Y, Okamoto R, Iwasaki T, Ookawa S, Aichi M, Yahiro M, Kida A, Nanami M. Long-acting erythropoiesis-stimulating agent (ESA) induces physiological erythropoiesis via improvement of iron availability. Int Urol Nephrol. 2022 May;54(5):1079-1084.
[3]https://www./DPM-HD/Japan/GetImage.aspx?n=ja_IVIRON_use_c_overallTAB.htm
[4]https://www./DPM-HD/Japan/GetImage.aspx?n=ja_hgbgdl_c_overallTAB.htm
[5]Shoji S, Inaba M, Tomosugi N, Okuno S, Ichii M, Yamakawa T, Kurihara S. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients. Eur J Haematol. 2013 Mar;90(3):237-44.